|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
RERO|A003176703
(VIAF cluster)
|
|
003
|
|
|
RERO |
|
005
|
|
|
20190127115726.0 |
|
008
|
|
|
190127 | acn||abb| n aaa d |
|
035
|
|
|
‡a
(RERO)A003176703
|
|
024
|
7 |
|
‡a
243022859
‡2
idref
|
|
035
|
|
|
‡a
vtls003176703
|
|
039
|
|
9 |
‡y
201901271157
‡z
VLOAD
|
|
040
|
|
|
‡a
RERO -rero-
|
|
100
|
1 |
|
‡a
Devlin, John P
|
|
901
|
|
|
‡a
978047187395
‡9
1
|
|
901
|
|
|
‡a
978082470067
‡9
1
|
|
909
|
|
|
‡a
(idref) 243022859
‡9
1
|
|
910
|
|
|
‡a
pulmonaryandantiallergicdrugs
‡A
Pulmonary and antiallergic drugs /
‡l
eng
‡9
1
|
|
910
|
|
|
‡a
highthroughputscreeningthediscoveryofbioactivesubstances
‡A
High throughput screening :
‡b
the discovery of bioactive substances /
‡l
eng
‡9
1
|
|
920
|
|
|
‡a
978-047
‡9
1
|
|
920
|
|
|
‡a
978-082
‡9
1
|
|
921
|
|
|
‡a
j wiley
‡b
J. Wiley,
‡9
1
|
|
921
|
|
|
‡a
m dekker
‡b
M. Dekker,
‡9
1
|
|
922
|
|
|
‡a
xxu
‡b
us
‡9
2
|
|
930
|
|
|
‡a
john p devlin
‡c
ed. by John P. Devlin
‡9
2
|
|
940
|
|
|
‡a
eng
‡9
2
|
|
943
|
|
|
‡a
198x
‡9
1
|
|
943
|
|
|
‡a
199x
‡9
1
|
|
944
|
|
|
‡a
am
‡9
2
|
|
996
|
|
|
‡2
ISNI|0000000379902973
|
|
996
|
|
|
‡2
WKP|Q6112096
|
|
996
|
|
|
‡2
ISNI|0000000114836499
|
|
996
|
|
|
‡2
WKP|Q16104849
|
|
996
|
|
|
‡2
WKP|Q111177198
|
|
996
|
|
|
‡2
LC|nr 00025869
|
|
996
|
|
|
‡2
SUDOC|111016002
|
|
996
|
|
|
‡2
ISNI|0000000122636710
|
|
996
|
|
|
‡2
N6I|vtls002107237
|
|
996
|
|
|
‡2
SUDOC|188647406
|
|
996
|
|
|
‡2
LC|nr 99012608
|
|
996
|
|
|
‡2
WKP|Q92535966
|
|
996
|
|
|
‡2
ISNI|0000000052769816
|
|
996
|
|
|
‡2
ISNI|0000000050293236
|
|
996
|
|
|
‡2
ISNI|0000000067347595
|
|
996
|
|
|
‡2
ISNI|0000000035386549
|
|
996
|
|
|
‡2
WKP|Q99484531
|
|
996
|
|
|
‡2
SUDOC|081003447
|
|
996
|
|
|
‡2
LC|n 2003006704
|
|
996
|
|
|
‡2
NKC|xx0322231
|
|
996
|
|
|
‡2
ISNI|0000000499933037
|
|
996
|
|
|
‡2
WKP|Q130268423
|
|
996
|
|
|
‡2
LC|no2011116909
|
|
996
|
|
|
‡2
J9U|987012726333005171
|
|
996
|
|
|
‡2
PLWABN|9810602339905606
|
|
996
|
|
|
‡2
LC|nb2007001394
|
|
996
|
|
|
‡2
DNB|1029066515
|
|
996
|
|
|
‡2
WKP|Q47452116
|
|
996
|
|
|
‡2
LC|nb2014023199
|
|
996
|
|
|
‡2
WKP|Q113674924
|
|
996
|
|
|
‡2
WKP|Q88893357
|
|
996
|
|
|
‡2
LC|nb2006001588
|
|
996
|
|
|
‡2
NDL|01055009
|
|
996
|
|
|
‡2
LC|n 96008557
|
|
996
|
|
|
‡2
WKP|Q113674887
|
|
996
|
|
|
‡2
SUDOC|185751431
|
|
996
|
|
|
‡2
DNB|1077117175
|
|
996
|
|
|
‡2
LC|nb2012019167
|
|
996
|
|
|
‡2
ISNI|0000000440079323
|
|
996
|
|
|
‡2
LC|no2018172832
|
|
996
|
|
|
‡2
WKP|Q89211845
|
|
996
|
|
|
‡2
WKP|Q54570332
|
|
996
|
|
|
‡2
N6I|vtls000060986
|
|
996
|
|
|
‡2
BIBSYS|3074731
|
|
996
|
|
|
‡2
DNB|1341943089
|
|
996
|
|
|
‡2
DNB|1177172968
|
|
996
|
|
|
‡2
BIBSYS|4011025
|
|
996
|
|
|
‡2
BIBSYS|99033746
|
|
996
|
|
|
‡2
ISNI|0000000449908204
|
|
996
|
|
|
‡2
ISNI|0000000458790287
|
|
996
|
|
|
‡2
SZ|1177172968
|
|
996
|
|
|
‡2
DNB|1254182365
|
|
996
|
|
|
‡2
WKP|Q95295766
|
|
996
|
|
|
‡2
NUKAT|n 2019004447
|
|
996
|
|
|
‡2
NUKAT|n 2021128391
|
|
996
|
|
|
‡2
WKP|Q6236777
|
|
996
|
|
|
‡2
NUKAT|n 2005084002
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
|
998
|
|
|
‡a
Devlin, John P.
‡2
SUDOC|243022859
‡3
standard number
|
|
998
|
|
|
‡a
Devlin, John P.
‡2
NTA|334080428
‡3
exact name
|
|
998
|
|
|
‡a
Devlin, John P.
‡2
NII|DA1284249X
‡3
exact title: (1.00, 'pulmonaryandantiallergicdrugs', 'pulmonaryandantiallergicdrugs')
|
|
998
|
|
|
‡a
Devlin, John P
‡2
NLA|000035291515
‡3
exact name
|
|
998
|
|
|
‡a
Devlin, John P.
‡2
LC|n 84025493
‡3
standard number
|
|
998
|
|
|
‡a
Devlin, John P.
‡2
ISNI|0000000067347595
‡3
exact name
|
|
998
|
|
|
‡a
Devlin, John P.
‡2
BIBSYS|98009539
‡3
viafid
‡3
standard number
|
|
998
|
|
|
‡a
Devlin, John P.
‡2
J9U|987007381436605171
‡3
viafid
‡3
exact title: (1.00, 'pulmonaryandantiallergicdrugs', 'pulmonaryandantiallergicdrugs')
|
|
999
|
|
|
‡2
REROBIB|vtls000986947
|
|
999
|
|
|
‡2
REROBIB|vtls003729176
|
